Trials / Unknown
UnknownNCT04071717
Real-time NIRS Neurofeedback Regulating Brain Cognitive Function in Obese Individuals
Real-time Neurofeedback Regulating Brain Cognitive Function in Obese Individuals: a Near-infrared Spectroscopy-based Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Wu Wenjun-1 · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To determine the efficacy of real-time fNIRS neurofeedback for regulating the brain cognitive function in obese individuals.
Detailed description
In the current study, 60 obese subjects will be recruited, and they were randomly classified into the group who will receive real neurofeedback and the group who will receive sham neurofeedback. Participants will receive the real-time neurofeedback for 12 times, 3 to 4 times a week, each time the real-time neurofeedback consists of 12 sessions of liftstone as the index reflecting the brain activity. Sham group will receive the identical neurofeedback. All of the subjects will undergo magnetic resonance imaging scan, during which T1, diffusion tensor imaging, resting-state, and task fMRI data will be collected. For task Fmri scan, the participants will be asked to finish four cognitive task, including 2-Back working memory, Go/No-Go task, Willingness to Pay for Food, and Delay Discounting tasks. Clinical measurements including BMI, eating behavior, psychiatric status will be assessed. Those aforementioned examinations will be performed at before the neurofeedback, 6th times and the end of the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | NIRS neurofeedback | Neurofeedback as a treatment for people which can be interpreted as a way to increase behavioral inhibition. A method to assess brain activity is functional near-infrared spectroscopy (NIRS), measuring hemodynamic correlates of neural activity. |
| BEHAVIORAL | Sham NIRS neurofeedback | Sham NIRS neurofeedback |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-08-28
- Last updated
- 2019-08-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04071717. Inclusion in this directory is not an endorsement.